Apyx Medical Corporation (APYX) |
|
3.15 0.08 (2.61%)
|
09-27 11:39 |
|
Open: |
3.14 |
Pre. Close: |
3.07 |
|
High:
|
3.4 |
Low:
|
3.063 |
|
Volume:
|
17,187 |
Market Cap:
|
109(M) |
|
|
|
Technical analysis |
as of: 2023-09-27 11:15:26 AM |
|
Short-term rate:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 4.86 One year: 5.66 |
| Support: |
Support1: 3.04 Support2: 2.53 |
| Resistance: |
Resistance1: 4.16 Resistance2: 4.84 |
| Pivot: |
3.8  |
| Moving Average: |
MA(5): 3.19 MA(20): 4
MA(100): 5.29 MA(250): 3.93 |
| MACD: |
MACD(12,26): -0.5 Signal(9): -0.4 |
| Stochastic oscillator: |
%K(14,3): 3.7 %D(3): 2 |
| RSI: |
RSI(14): 27.5 |
| 52-week: |
High: 7.96 Low: 1.3 |
| Average Vol(K): |
3-Month: 209 (K) 10-Days: 89 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ APYX ] has closed above bottom band by 20.5%. Bollinger Bands are 0% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.23 - 3.26 |
3.26 - 3.28 |
|
Low:
|
2.99 - 3.03 |
3.03 - 3.05 |
|
Close:
|
3.02 - 3.09 |
3.09 - 3.13 |
|
Company Description |
|
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida. |
Headline News |
Wed, 27 Sep 2023
Cold Plasma Market Size, Share & Trends Research Report [2023-2029] - Benzinga
Wed, 27 Sep 2023
Cold Plasma Market Poised for Remarkable Growth Anticipated to ... - Digital Journal
Tue, 26 Sep 2023
Cold Plasma Market Growth Overview Future Developments ... - Digital Journal
Sun, 17 Sep 2023
Short Interest in Apyx Medical Co. (NASDAQ:APYX) Drops By 16.7% - MarketBeat
Tue, 15 Aug 2023
Apyx Medical Corporation (NASDAQ:APYX) Q2 2023 Earnings Call Transcript - Yahoo Finance
Thu, 06 Jul 2023
Apyx Medical (APYX) Price Target Increased by 9.09% to 9.18 - Nasdaq
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
35 (M) |
| Shares Float |
21 (M) |
|
% Held by Insiders
|
12.7 (%) |
|
% Held by Institutions
|
72.2 (%) |
|
Shares Short
|
2,850 (K) |
|
Shares Short P.Month
|
2,450 (K) |
Stock Financials |
|
EPS
|
-0.45 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.05 |
|
Profit Margin (%)
|
-34.4 |
|
Operating Margin (%)
|
-44.8 |
|
Return on Assets (ttm)
|
-21.8 |
|
Return on Equity (ttm)
|
-39.6 |
|
Qtrly Rev. Growth
|
31.7 |
|
Gross Profit (p.s.)
|
0.84 |
|
Sales Per Share
|
1.36 |
|
EBITDA (p.s.)
|
-0.6 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-17 (M) |
|
Levered Free Cash Flow
|
-13 (M) |
Stock Valuations |
|
PE Ratio
|
-7.16 |
|
PEG Ratio
|
-0.9 |
|
Price to Book value
|
3.03 |
|
Price to Sales
|
2.35 |
|
Price to Cash Flow
|
-6.72 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
